GLP-1s and Pancreatitis: What to Know

Pancreatitis — inflammation of the pancreas — is listed as a rare but serious adverse reaction for GLP-1 medications including semaglutide and tirzepatide. The cardinal warning sign is severe abdominal pain that may radiate to the back. If you experience this, seek urgent medical attention. Here's what to understand about the risk.

What is pancreatitis and why is it relevant to GLP-1s?

The pancreas is a gland that produces digestive enzymes and hormones, including insulin. Pancreatitis is inflammation of the pancreas, which occurs when digestive enzymes become active inside the gland itself and begin to damage it. It can be acute (sudden onset) or chronic (recurring or persistent).

GLP-1 receptors are present in pancreatic tissue, and early concerns arose about whether GLP-1 medications might increase pancreatitis risk. Large cardiovascular outcomes trials — including SUSTAIN-6 and others — have not shown a statistically significant increase in pancreatitis rates in the overall trial populations. However, pancreatitis remains listed in the prescribing information for GLP-1 medications as an adverse reaction, and clinicians are advised to consider it, particularly in patients with risk factors.

Risk factors for pancreatitis include a history of pancreatitis, heavy alcohol use, high triglycerides, and gallstones — the latter being independently more common during rapid weight loss on a GLP-1.

What are the warning signs?

The key warning signs of pancreatitis are:

• Severe, persistent pain in the upper or middle abdomen — often described as constant, not cramp-like
• Pain that radiates through to the back
• Pain that does not improve with position changes
• Nausea and vomiting — often accompanying the pain
• The pain may be worse after eating

This is distinct from the common, mild GI side effects of GLP-1 medications (nausea, general abdominal discomfort, constipation), which are typically milder, often linked to dose increases, and usually improve over time. Pancreatitis pain is typically severe, persistent, and does not resolve with standard approaches.

If you experience severe, persistent abdominal pain — especially if it radiates to the back — seek urgent medical attention. This is not a symptom to wait and see about.

How rare is pancreatitis on a GLP-1?

Pancreatitis is considered a rare adverse reaction for GLP-1 medications. It appears in prescribing information as a risk that prescribers and patients should be aware of — not as a common occurrence. Large trials have not shown a clear excess risk above the background rate of pancreatitis in the trial populations studied.

However, "rare" means it does happen. Awareness of the symptoms allows for prompt action, which is what matters most for outcomes. Do not dismiss severe abdominal pain as a GLP-1 GI side effect without medical assessment.

What should I do if I experience symptoms?

If you develop severe, persistent abdominal pain — particularly if it radiates to the back — the right action is:

• Seek urgent medical attention — go to an emergency department or call emergency services if pain is severe
• Do not continue the GLP-1 injection if you are in the window for your next dose and have not yet taken it — wait until you have been assessed
• Tell the treating clinician that you are on a GLP-1 medication and what dose

If you have a history of pancreatitis, make sure your prescribing clinician knows before you start a GLP-1. This is a relevant piece of medical history that affects the risk-benefit assessment. Some clinicians consider a history of pancreatitis a relative or absolute contraindication — your clinician will advise.

Frequently asked questions

Is pancreatitis common on GLP-1 medications?
Pancreatitis is listed as an adverse reaction but is considered rare. The prescribing information includes it as a risk to be aware of, not as something most people will experience.

What does pancreatitis feel like?
The typical presentation is severe, persistent pain in the upper or middle abdomen, often radiating through to the back, sometimes accompanied by nausea and vomiting. It usually doesn't improve with position changes. If you experience this, seek urgent medical care.

I've had pancreatitis before — can I take a GLP-1?
A history of pancreatitis is something to discuss with your prescribing clinician. It may be a contraindication or require extra caution — your clinician will assess whether the benefit outweighs the risk in your case.

How do I distinguish pancreatitis pain from ordinary GI side effects?
Common GLP-1 GI side effects (nausea, mild abdominal discomfort) are generally mild and often linked to eating or dose increases. Pancreatitis pain is typically severe, persistent, and not resolved by standard approaches. If in doubt, seek medical attention.